AI assistant
Sending…
LABCORP HOLDINGS INC. — Director's Dealing 2021
Apr 1, 2021
30237_dirs_2021-04-01_083fe8f1-65a8-4cca-afb0-19a1ca953a58.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2021-03-30
Reporting Person: Schroeder Mark S (EVP, President-Diagnostics Lab)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-03-30 | Common Stock | S | 667 | $251.88 | Disposed | 5006.3789 | Direct |
Footnotes
F1: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.
More from LABCORP HOLDINGS INC.
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 22
Interim / Quarterly Report
2026
May 4
Regulatory Filings
2026
Apr 30
Annual Report
2026
Apr 10
Proxy Solicitation & Information Statement
2026
Apr 10
Regulatory Filings
2026
Apr 9
Regulatory Filings
2026
Mar 31
Director's Dealing
2026
Mar 30
Director's Dealing
2026
Mar 30